Abstract
The article delves into the multifaceted landscape of exotic pet medicine in Europe, exploring the impact of Brexit, evolving legislation surrounding exotic pet keeping, and challenges posed by the COVID-19 pandemic and the cost-of-living crisis. Regulatory changes, particularly in veterinary medication use, are discussed alongside the emergence of corporate entities in the veterinary industry. The article also underscores the need for improved education in exotic pet medicine and postgraduate qualifications. Overall, it provides a comprehensive overview of the dynamic factors shaping the practice, regulation, and education of exotic pet medicine across European countries.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
